What type of study is this?

December 4, 2025JAMA Network OpenOpen Access

Continuous Glucose Monitoring in Insulin-Treated Older Adults With Diabetes and Alzheimer Disease and Related Dementias

View Full Paper

Ask AI

Bookmark

Authors

PKPareeta Kotecha SSSteven M. Smith WDWILLIAM T. DONAHOO

Discussion

Member takes

Implication

Retrospective cohort study shows continuous glucose monitoring lowers hospitalization and mortality risks in older adults with diabetes and Alzheimer's disease, indicating potential benefits of CGM.

Key Points

CGM use significantly reduced all-cause hospitalizations, achieving a hazard ratio of 0.86 compared to SMBG use.
Among 2022 insulin-treated older adults aged ≥66, CGM users showed a major drop in all-cause mortality with a hazard ratio of 0.57.
The study employed a propensity score matching method to create balanced CGM and SMBG user cohorts for comparative analysis.
Findings suggest CGM may improve outcomes but highlight the necessity for larger pragmatic trials to evaluate effectiveness and implementation.

Cite This Study

Kotecha et al. (2025) studied this question.

synapsesocial.com/papers/6930e8dbea1aef094cca3cda https://doi.org/10.1001/jamanetworkopen.2025.41939

View Full Paper

Ask AI

Bookmark

Implication

Retrospective cohort study shows continuous glucose monitoring lowers hospitalization and mortality risks in older adults with diabetes and Alzheimer's disease, indicating potential benefits of CGM.

Continuous Glucose Monitoring in Insulin-Treated Older Adults With Diabetes and Alzheimer Disease and Related Dementias

Discussion

Member takes

Implication

Key Points

Cite This Study

Continuous Glucose Monitoring in Insulin-Treated Older Adults With Diabetes and Alzheimer Disease and Related Dementias

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider